Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction

被引:37
|
作者
Ahmad, Ijaz [1 ,2 ,3 ]
Huang, Lingli [1 ,2 ]
Hao, Haihong [4 ]
Sanders, Pascal [5 ]
Yuan, Zonghui [1 ,2 ,4 ]
机构
[1] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan 430070, Hubei, Peoples R China
[2] Huazhong Agr Univ, MAO Key Lab Detect Vet Drug Residues, Wuhan 430070, Hubei, Peoples R China
[3] Univ Agr Peshawar, Khyber Pakhtunkhwa 25130, Pakistan
[4] Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan 430070, Hubei, Peoples R China
[5] French Agcy Food Environm & Occupat Safety, Lab Fougeres, F-94701 Maisons Alfort, France
关键词
MUTANT PREVENTION CONCENTRATIONS; ANTIBIOTIC-RESISTANCE; IN-VITRO; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; PHARMACOKINETIC/PHARMACODYNAMIC INTEGRATION; PHARMACODYNAMIC INTEGRATION; PSEUDOMONAS-AERUGINOSA; MANNHEIMIA-HAEMOLYTICA;
D O I
10.1155/2016/5465678
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Among veterinary drugs, antibiotics are frequently used. The true mean of antibiotic treatment is to administer dose of drug that will have enough high possibility of attaining the preferred curative effect, with adequately low chance of concentration associated toxicity. Rising of antibacterial resistance and lack of novel antibiotic is a global crisis; therefore there is an urgent need to overcome this problem. Inappropriate antibiotic selection, group treatment, and suboptimal dosing are mostly responsible for the mentioned problem. One approach to minimizing the antibacterial resistance is to optimize the dosage regimen. PK/PD model is important realm to be used for that purpose from several years. PK/PD model describes the relationship between drug potency, microorganism exposed to drug, and the effect observed. Proper use of the most modern PK/PD modeling approaches in veterinary medicine can optimize the dosage for patient, which in turn reduce toxicity and reduce the emergence of resistance. The aim of this review is to look at the existing state and application of PK/PD in veterinary medicine based on in vitro, in vivo, healthy, and disease model.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes
    Zager, Michael G.
    Kozminski, Kirk
    Pascual, Bernadette
    Ogilvie, Kathleen M.
    Sun, Shaoxian
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (02) : 127 - 139
  • [32] Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes
    Michael G. Zager
    Kirk Kozminski
    Bernadette Pascual
    Kathleen M. Ogilvie
    Shaoxian Sun
    Journal of Pharmacokinetics and Pharmacodynamics, 2014, 41 : 127 - 139
  • [33] Mathematical modeling and computational prediction of cancer drug resistance
    Sun, Xiaoqiang
    Hu, Bin
    BRIEFINGS IN BIOINFORMATICS, 2018, 19 (06) : 1382 - 1399
  • [34] Formulation optimization and PK/PD evaluation of novel valsartan bilosomes enhancing transdermal drug delivery
    Peddapalli, Himabindu
    Radha, G. V.
    Chinnaiyan, Santhosh Kumar
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 92
  • [35] Relating tumor drug concentrations to target effect with semi-physiologic PK-PD modeling in drug development: an application using a novel dCK inhibitor
    Nikanjam, Mina
    Poddar, Soumya
    Capparelli, Edmund
    Thuc Le
    Wei, Liu
    Radu, Caius
    CANCER RESEARCH, 2017, 77
  • [36] Establishing in vitro–in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach
    Dhaval K. Shah
    Frank Loganzo
    Nahor Haddish-Berhane
    Sylvia Musto
    Hallie S. Wald
    Frank Barletta
    Judy Lucas
    Tracey Clark
    Steve Hansel
    Alison Betts
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 339 - 349
  • [37] Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
    Wang, Chuhui
    Zhang, Chao
    Li, Xiaoxiao
    Zhao, Sixuan
    He, Na
    Zhai, Suodi
    Ge, Qinggang
    ANTIBIOTICS-BASEL, 2021, 10 (11):
  • [38] PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation
    Caruso, Antonello
    Alvarez-Sanchez, Ruben
    Hillebrecht, Alexander
    Poirier, Agnes
    Schuler, Franz
    Lave, Thierry
    Funk, Christoph
    Belli, Sara
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (11) : 1684 - 1699
  • [39] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
    Danhof, Meindert
    de Lange, Elizabeth C. M.
    Della Pasqua, Oscar E.
    Ploeger, Bart A.
    Voskuyl, Rob A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (04) : 186 - 191
  • [40] Multiorgan-on-a-chip for cancer drug pharmacokinetics-pharmacodynamics (PK-PD) modeling and simulations
    Abdurehman Eshete Mohammed
    Filiz Kurucaovalı
    Devrim Pesen Okvur
    Journal of Pharmacokinetics and Pharmacodynamics, 2025, 52 (1)